Skip to main content

Table 1 Association between the expression level of miR-133a-3p or GAPARAPL1 and the clinical characteristics in GC patients

From: Novel role of miR-133a-3p in repressing gastric cancer growth and metastasis via blocking autophagy-mediated glutaminolysis

Parameters Group miR-133a-3p expression GABARAPL1 expression
Cases Low High P-value Cases Low High P-value
Gender female
male
24
56
13
27
11
29
0.6256 15
35
7
18
8
17
0.7576
Age at surgery ≥ 55
<  55
64
16
29
11
35
5
0.0935 7
43
5
20
2
23
0.2214
T grade T1 + T2
T3 + T4
45
35
21
19
24
16
0.4990 24
26
14
11
10
15
0.2575
Lymphatic invasion Negative(N0)
Positiv(N1-N3)
23
57
7
33
16
24
0.0262* 20
30
12
13
8
17
0.2482
Tumor site Cardiac
Non-cardiac
30
50
16
24
14
26
0.6442 18
32
12
13
6
19
0.0771
Stage I-II
III-IV
41
39
18
22
23
17
0.2634 23
27
14
11
9
16
0.1560
Size(cm) <  3
≥ 3
37
43
13
27
24
162
0.0136* 21
29
14
11
7
18
0.0449*
Histology grade Well-moderately
Poorly-signet
25
55
15
25
10
30
0.2278 0. 17
33
10
15
7
18
0.3705
  1. P < 0.05 represents statistical significance (Chi-square test)